Molecular diagnostic test for simultaneous detection of Mycobacterium tuberculosis and nontuberculous mycobacteria. Enables rapid differentiation between mycobacterial species.
Manufactured by
Genesystem Co., Ltd.
Daejeon, South Korea
Where Precision Meets Convenience : Inspiring Point-of-Care Molecular Diagnostics Genesystem is a biotech engineering company from South Korea specializing in molecular diagnostic solutions to target point-of-care testing applications. Genesystem develops and markets state-of-the-art diagnostic platforms for precise and convenient tests using its unique biochip technology.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Pilot Gene Technology (Hangzhou) Co., Ltd.
China · 2 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 4 relevant products
Zeesan Biotech Co., Ltd
China · 13 relevant products
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 111 closest product alternatives
Pilot Gene Technology (Hangzhou) Co., Ltd. · China
dPCR assay for rapid and accurate detection of Mycobacterium tuberculosis and nontuberculous mycobacteria in clinical samples. Enables simultaneous identification of MTB and NTM species.
HLB PANAGENE Co., Ltd. · South Korea
A diagnostic test for tuberculosis and non-tuberculous mycobacteria detection in tissue biopsy samples.
Zeesan Biotech Co., Ltd · China
Molecular diagnostic test kit for detection and identification of multidrug-resistant tuberculosis (MDR-TB) using nucleic acid analysis. Enables rapid molecular characterization of TB strains to guide targeted treatment decisions in clinical and laboratory settings.
108 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products